The Significance of Outer Retinal Injury in Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$89,562
Active Dates
April 01, 2006 - March 31, 2008
Grant ID
G2006016
Summary
Chronic glaucoma results in the loss of retinal ganglion cells. Much of basic glaucoma research has, appropriately, focused on these cells and their axonal connections as they pass through the optic nerve. However, previous work by the principal investigator and by other laboratories have now established that the outer retina (specifically, the photoreceptors) is also affected in both human chronic glaucoma and in a non-human primate model of chronic glaucoma. The significance of this finding is unknown. Dr. Nork plans to apply new research methodologies for examining the relationship between the blood supply to the outer retina and the retinal pathology found in glaucoma.Blindness in glaucoma is caused by retinal ganglion cell loss. Direct injury (either mechanical or vascular) to the optic nerve most likely represents a significant effect. Even so, outer retinal ischemia may play a contributory role in RGC death. With this research into the regional effects of retinal damage in animal models of glaucoma, Dr. Nork hopes to test if outer and inner retinal injury in glaucoma are related. If these and other studies show this to be the case, it could lead to new pathways for pharmacologic intervention in this often inadequately controlled disease process.
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
National Glaucoma Research
Human Retinal Regeneration to Cure Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Karl Wahlin, PhD
Current Organization
University of California, San Diego
Human Retinal Regeneration to Cure Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Karl Wahlin, PhD
Current Organization
University of California, San Diego